feed,title,long_url,short_url
SeekingAlpha,Adaptimmune provides complete contents of its SITC Abstract for SURPASS Trial,https://seekingalpha.com/news/3622851,
SeekingAlpha,MacroGenics reports that AML patients benefit from flotetuzumab immunotherapy,https://seekingalpha.com/news/3622852,
